Wei Qu

255 papers receiving 7.4k citations

Peers

Wei Qu
Comparison fields: 5 of 163
  • Biochemistry 649
  • Pharmacology 770
  • Pharmacology 921
  • Molecular Biology 3.5k
  • Biomaterials 627
Replace Parames C. Sil with:
Parames C. Sil India
Tsong‐Long Hwang Taiwan
Maret G. Traber United States
Ying‐Jan Wang Taiwan
Teruo Miyazawa Japan
Paulo J. Oliveira Portugal
Maria de Lourdes Bastos Portugal
Madalena Pinto Portugal
Seppo Auriola Finland
Jeffrey D. Laskin United States
Wei Qu relative to Parames C. Sil India Parames C. Sil's profile →
Citations per field
00.5×1.5×2.0×
Parames C. Sil · 1×
Citations per year

Countries citing papers authored by Wei Qu

Since Specialization
Citations

This map shows the geographic impact of Wei Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Qu more than expected).

Fields of papers citing papers by Wei Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Qu. The network helps show where Wei Qu may publish in the future.

Co-authors

The 25 scholars most cited alongside Wei Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei Qu Line = papers co-authored together Wei Qu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 261 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2003328
2 2019217
3 2003196
4 2013194
5 2007180
6 2018171
7 2020170
8 2008152
9 2015149
10 2014109
11 2012107
12 2006102
13 201498
14 201395
15 199989
16 199989
17 202089
18 201888
19 202187
20 201085

About Wei Qu

Wei Qu is a scholar working on Pharmacology, Biochemistry, Pharmacology, Molecular Biology and Complementary and alternative medicine, having authored 261 papers that have together received 7.6k indexed citations. Recurring topics across this work include Natural product bioactivities and synthesis (23 papers), Phytochemical compounds biological activities (17 papers), Nanoplatforms for cancer theranostics (16 papers), Advanced biosensing and bioanalysis techniques (15 papers), Phytochemistry and Biological Activities (15 papers), RNA Interference and Gene Delivery (12 papers), Traditional and Medicinal Uses of Annonaceae (11 papers) and Cholinesterase and Neurodegenerative Diseases (11 papers). The work is most often cited by research in Biochemistry (649 citations), Pharmacology (770 citations), Pharmacology (921 citations), Molecular Biology (3.5k citations) and Biomaterials (627 citations). Wei Qu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Feng Feng, Michael P. Waalkes, Wenyuan Liu, Haopeng Sun, Jingbo Pi, Jian Xu, Jingyu Liang, Siyu He, William E. Achanzar and M Takiguchi. Their work appears in journals such as Chinese Journal of Natural Medicines, Journal of Ethnopharmacology, Chemistry & Biodiversity, Bioorganic Chemistry and European Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026